Klaudia Konikowska

Dr. Klaudia Konikowska

Wroclaw Medical University, Wroclaw, Poland
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 January 2023 in Biomedicines
Verified
Journal Article
Open access
PDF file
KKKlaudia Konikowska
Klaudia Konikowska
WBWojciech Bombała
Wojciech Bombała
ASAndrzej Szuba
Andrzej Szuba
DRDorota Różańska
Dorota Różańska
BRBożena Regulska-Ilow
Bożena Regulska-Ilow
The current study was designed to examine the relationship between diet quality, as measured by the Dietary Approaches to Stop Hypertension (DASH) score, and the prevalence of metabolic syndrome (MetS) and its components. The study was cross-sectional in design and enrolled 535 people, including 215 with MetS and 320 without MetS. Using a validated food frequency questionnaire, the DASH diet quality score was counted. The mean age of the MetS group and control subjects was 58.48 ± 14.65 and 58.33 ± 9.26 years, respectively. The study showed that the MetS group had a significantly lower mean total DASH score than the control group (23.13 ± 5.44 vs. 24.62 ± 5.07, p = 0.0023). In addition, it was found that an increase in the total DASH score was associated with a lower risk of MetS (odds ratio [OR] = 0.95, 95% confidence interval [CI] = 0.91–0.99, p = 0.009). In the correlation analysis of the total population, a better-quality diet (higher DASH score) was positively correlated with high-density lipoprotein cholesterol (HDL-c), and negatively correlated with triglyceride (TG) concentration and waist circumference. It was also found that an increase in the total DASH score was associated with a lower risk of abdominal obesity (OR = 0.93, 95% CI = 0.88–0.99, p = 0.017). The results from the analyzed data highlight the potential benefits of following a healthy diet such as DASH.

5 October 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
KKKlaudia Konikowska
Klaudia Konikowska
WBWojciech Bombała
Wojciech Bombała
ASAndrzej Szuba
Andrzej Szuba
DRDorota Różańska
Dorota Różańska
BRBożena Regulska-Ilow
Bożena Regulska-Ilow
Presenting diet quality of patients with metabolic syndrome (MetS), using a holistic approach is more useful than investigating dietary individual components, but there is still a small amount of research in this area. The aim of this study assessed the diet quality, as measured by the HEI-2015, of MetS patients compared to healthy individuals. The study and control group consisted of 215 patients with MetS and 320 people without MetS, respectively. A nutritional analysis using a semi-quantitative food frequency questionnaire was used to evaluate the nutritional habits in the study and control group. Total HEI-2015 scores were significantly lower in MetS subjects than in those in the control group (65.04 ± 9.71 vs. 66.75 ± 8.88) and the quality of women’s diets was better than the quality of men’s diet (66.83 ± 8.99 vs. 64.75 ± 9.57). We also observed that low HDL-c concentration increased the risk of MetS in the general population the most. Across the population, there was a weak positive correlation between HDL-c concentrations and total HEI-2015 scores and a weak negative correlation between mean waist circumference values and total HEI-2015 scores. HDL-c concentrations may be a key factor in the prevention of MetS and appropriate therapeutic management to increase HDL-c levels may be of key importance in patients diagnosed with MetS.

25 November 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Katarzyna Kilis-PstrusinskaKatarzyna Kilis-Pstrusinska
Katarzyna Kilis-Pstrusinska
KAKatarzyna Akutko
Katarzyna Akutko
JBJoanna Barbara Braksator
Joanna Barbara Braksator
ADAnna Dancewicz
Anna Dancewicz
PGPatrycja Grosman-Dziewiszek
Patrycja Grosman-Dziewiszek
EJEwa Jankowska
Ewa Jankowska
The disease caused by coronavirus SARS-CoV-2 (COVID-19) can affect almost all organs of the human body, including kidneys. We conducted a one-center study to comprehensively analyze the effects of kidney involvement on the course and outcomes in patients hospitalized with COVID-19, depending on the estimated glomerular filtration rate (eGFR) at admission. Out of the 1958 patients, 1342 (68.54%) had eGFR ≥ 60 mL/min/1.73 m2 (group A) and 616 (31.46%) had eGFR < 60 mL/min/1.73 m2 (group B). Group B was additionally divided into subgroups B1, B2, and B3 based on eGFR. We found that mortality rates during hospitalization, as well as after 90 and 180 days, were much higher in group B than group A. The highest mortality was observed in the B2 subgroup with eGFR of 15–29. The mortality of B patients was associated with comorbidities, respiratory dysfunction, immunological impairment, and more frequent development of AKI. AKI had a negative impact on patients’ survival, regardless of the initial renal function. At discharge, 7.4% of patients had serum creatinine levels 30% higher, or more, as compared to admission. The disease course and outcomes in COVID-19 patients are associated with baseline eGFR; however, AKI during hospitalization is a more significant predictor of poor prognosis regardless of the initial renal function.

1 September 2023 in Frontiers in Immunology
Verified
Journal Article
Open access
KKKlaudia Konikowska
Klaudia Konikowska
KKKatarzyna Kiliś-Pstrusińska
Katarzyna Kiliś-Pstrusińska
AMAgnieszka Matera-Witkiewicz
Agnieszka Matera-Witkiewicz
KKKrzysztof Kujawa
Krzysztof Kujawa
BABarbara Adamik
Barbara Adamik
EJEwa Anita Jankowska
Ewa Anita Jankowska
Background: Vitamin D deficiency is a substantial public health problem. The present study evaluated the association between vitamin D concentration and hospitalization and mortality risk in patients with coronavirus disease 19 (COVID-19).Methods: This study used the COronavirus in LOwer Silesia (COLOS) dataset collected between February 2020 and June 2021. The medical records of 474 patients with confirmed severe acute respiratory syndrome 2 (SARS-CoV-2) infection, and whose vitamin D concentration was measured, were analyzed.Results: We determined a significant difference in vitamin D concentration between discharged patients and those who died during hospitalization (p = 0.0096). We also found an effect of vitamin D concentration on the risk of death in patients hospitalized due to COVID-19. As vitamin D concentration increased, the odds ratio (OR) for death slightly decreased (OR = 0.978; 95% confidence interval [CI] = 0.540-0.669). The vitamin D concentration cutoff point was 15.40 ng/ml. In addition, patients with COVID-19 and serum 25-hydroxyvitamin D (25(OH)D) concentrations < 30 ng/ml had a lower survival rate than those with serum 25(OH)D ≥ 30 ng/ml (log-rank test p = 0.0018). Moreover, a Cox regression model showed that patients with an estimated glomerular filtration rate (eGFR) ≥ 60 ml/min/1.73 m2 and higher vitamin D concentrations had a 2.8% reduced risk of mortality (hazard ratio HR = 0.972; CI = 0.95-0,99; p = 0.0097).Conclusions: The results indicate an association between 25(OH)D levels in patients with COVID-19 and the final course of hospitalization and risk of death.

7 February 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
DGDamian Gajecki
Damian Gajecki
ADAdrian Doroszko
Adrian Doroszko
Malgorzata TrochaMalgorzata Trocha
Malgorzata Trocha
KGKatarzyna Giniewicz
Katarzyna Giniewicz
KKKrzysztof Kujawa
Krzysztof Kujawa
KMKatarzyna Madziarska
Katarzyna Madziarska
Background: Diabetes mellitus is among the most frequent comorbidities worsening COVID-19 outcome. Nevertheless, there are no data regarding the optimal risk stratification of patients with diabetes and COVID-19. Since individual C2HEST components reflect the comorbidities, we assumed that the score could predict COVID-19 outcomes. Material and Methods: A total of 2184 medical records of patients hospitalized for COVID-19 at the medical university center were analyzed, including 473 diabetic patients and 1666 patients without any glucose or metabolic abnormalities. The variables of patients’ baseline characteristics were retrieved to calculate the C2HEST score and subsequently the diabetic and non-diabetic subjects were assigned to the following categories: low-, medium- or high-risk. The measured outcomes included: in-hospital mortality; 3-month and 6-month all-cause mortality; non-fatal end of hospitalization (discharged home/sudden-deterioration/rehabilitation) and adverse in-hospital clinical events. Results: A total of 194 deaths (41%) were reported in the diabetic cohort, including 115 in-hospital deaths (24.3%). The 3-month and 6-month in-hospital mortality was highest in the high-risk C2HEST stratum. The C2HEST score revealed to be more sensitive in non-diabetic-group. The estimated six-month survival probability for high-risk subjects reached 0.4 in both cohorts whereas for the low-risk group, the six-month survival probability was 0.7 in the diabetic vs. 0.85 in the non-diabetic group—levels which were maintained during whole observation period. In both cohorts, receiver operating characteristics revealed that C2HEST predicts the following: cardiogenic shock; acute heart failure; myocardial injury; and in-hospital acute kidney injury. Conclusions: We demonstrated the usefulness and performance of the C2HEST score in predicting the adverse COVID-19 outcomes in hospitalized diabetic subjects.

1 January 2024 in Engineering Sciences And Technologies
Verified
Journal Article
Open access
PDF file
AOAgata Olszar
Agata Olszar
Ewelina Ewa KsiążekEwelina Ewa Książek
Ewelina Ewa Książek
KKKlaudia Konikowska
Klaudia Konikowska
Aim: With the growing reliance on mobile apps by individuals with allergies and food intolerances, this study aimed to evaluate their quality and usability. Using the Mobile Application Rating Scale (MARS), we assessed allergy-related apps available on Google Play and the AppStore. Methodology: Using the PRISMA elimination method (Preferred Reporting Items for Systematic Reviews and Meta-Analyses), three apps were selected from the available options: Soosee – Allergy & Vegan Scan, The Gluten Free Scanner, and Eat Smart Kiwi: Food Diary. The respondents used these apps for a period of two weeks. Next, the researchers completed the MARS questionnaire, comprising five sections. The apps were evaluated in the categories of engagement, functionality, aesthetics, information content, and subjective quality assessment. Results: The study revealed that one of the apps, namely Soosee – Allergy & Vegan Scan, received the highest ratings among the apps evaluated, surpassing Eat Smart Kiwi: Food Diary and The Gluten Free Scanner, which received the lowest rating. Analysis of user preferences indicated that the aesthetics of the interface play a crucial role in the perception of mHealth mobile apps, particularly those related to food allergies. An attractive graphical interface significantly impacts user satisfaction and engagement. Notably, the ratings given by the study participants did not align with those seen on Google Play and the AppStore, suggesting potential differences in user expectations and needs depending on usage context and the more detailed assessment conducted in this study. Implications and recommendations: With numerous mobile apps available, quality assessment is crucial as users often lack the knowledge to evaluate them effectively. While mHealth apps have the potential to improve daily life for individuals with allergies, they must offer an intuitive design, verified information, and user-friendly interfaces to meet expectations. Originality/value: This study provides a comprehensive evaluation of allergy-related mobile apps using a standardized assessment tool (MARS), offering a more structured analysis than general user ratings. By highlighting discrepancies between expert-based evaluations and user reviews, the research underscores the need for more transparent quality indicators in mHealth applications.